Weiss Ratings restated their sell (d-) rating on shares of 4D Molecular Therapeutics (NASDAQ:FDMT – Free Report) in a report released on Saturday morning,Weiss Ratings reports. A number of other ...

RBC Capital analyst Darko Mihelic maintained a Buy rating on Sun Life Financial (SLF – Research Report) yesterday and set a price target of ...

On Friday, Exelixis Inc (EXEL) stock saw a decline, ending the day at $36.2 which represents a decrease of $-0.35 or -0.96% from the prior close of $36.55. The stock opened at $36.76 and touched a low ...

Victory Capital (NASDAQ:VCTR – Free Report) had its target price upped by Barclays from $69.00 to $70.00 in a report released on Friday morning,Benzinga reports. Barclays currently has an equal weight ...

In a report released on January 16, Gerard Cassidy from RBC Capital maintained a Buy rating on PNC Financial (PNC – Research Report), with a ...

The Municipal Securities Rulemaking Board Thursday announced the members of its 2025 advisory groups, including those tapped for a new group that will focus on the intersection of technological ...

Investing.com - Strong US economic indicators and corporate returns this week have likely whetted the appetite for riskier ...

Standard Chartered printed a $1bn four year non-call three bond at 105bp over US Treasuries, and a $1bn 11 year non-call 10 ...

RBC Capital Markets adjusted its outlook on shares of JPMorgan Chase & Co. (NYSE: NYSE:JPM) shares by increasing the price ...

BMO Capital Markets has recently reduced Exelixis Inc (EXEL) stock to Market Perform rating, as announced on December 20, 2024, according to Finviz. Earlier, on December 17, 2024, BofA Securities had ...

Analysts expect the Stamford, Connecticut-based company to report quarterly earnings at $1.35 per share, down from $1.46 per ...

Swiss luxury group Richemont said it saw an improvement across all business areas and reported better-than-expected sales for its fiscal third quarter, in the midst of a downward trend in demand for ...